GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | 8/14/2026 7:33:25 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $935,000 | Assets $125,249,000 | EPS -$0.23 | |
| Neumora Therapeutics, Inc. (NMRA) | 8/14/2026 7:13:58 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $935,000 | Assets $125,249,000 | EPS -$0.23 | Export Earnings Model | |
| Neumora Therapeutics, Inc. (NMRA) | 5/7/2026 4:13:30 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,231,000 | Assets $153,877,000 | EPS -$0.30 | |
| Neumora Therapeutics, Inc. (NMRA) | 5/7/2026 7:16:44 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,231,000 | Assets $153,877,000 | EPS -$0.30 | Export Earnings Model | |
| Neumora Therapeutics, Inc. (NMRA) | 4/17/2026 4:06:29 PM | View | Proxy | SEC | Y 2025 | ||||||
| Neumora Therapeutics, Inc. (NMRA) | 3/30/2026 7:12:23 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $8,344,000 | Assets $191,047,000 | EPS -$1.45 | |
| Neumora Therapeutics, Inc. (NMRA) | 3/30/2026 6:59:24 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $1,335,000 | Assets $191,047,000 | EPS -$0.35 | Export Earnings Model | |
| Neumora Therapeutics, Inc. (NMRA) | 11/6/2025 4:14:10 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,685,000 | Assets $177,833,000 | EPS -$0.35 | |
| Neumora Therapeutics, Inc. (NMRA) | 11/6/2025 7:08:49 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,685,000 | Assets $177,833,000 | EPS -$0.35 | Export Earnings Model | |
| Neumora Therapeutics, Inc. (NMRA) | 8/6/2025 4:44:28 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $223,825,000 | EPS -$0.33 | ||
| Neumora Therapeutics, Inc. (NMRA) | 8/6/2025 4:08:13 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $223,825,000 | EPS -$0.33 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 5/12/2025 4:44:25 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $256,748,000 | EPS -$0.42 | ||
| Neumora Therapeutics, Inc. (NMRA) | 5/12/2025 4:05:57 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $256,748,000 | EPS -$0.42 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 4/29/2025 4:08:38 PM | View | Proxy | SEC | Y 2024 | ||||||
| Neumora Therapeutics, Inc. (NMRA) | 3/3/2025 7:45:59 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $316,972,000 | EPS -$1.53 | ||
| Neumora Therapeutics, Inc. (NMRA) | 3/3/2025 7:07:18 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $316,972,000 | EPS -$0.37 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 11/12/2024 4:34:29 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $352,537,000 | EPS -$0.45 | ||
| Neumora Therapeutics, Inc. (NMRA) | 11/12/2024 9:23:19 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $352,537,000 | EPS -$0.45 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 8/6/2024 4:17:40 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $404,473,000 | EPS -$0.37 | ||
| Neumora Therapeutics, Inc. (NMRA) | 8/6/2024 7:16:44 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $404,473,000 | EPS -$0.37 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 5/7/2024 4:14:36 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $450,211,000 | EPS -$0.34 | ||
| Neumora Therapeutics, Inc. (NMRA) | 5/7/2024 7:16:19 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $450,211,000 | EPS -$0.34 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 4/25/2024 4:20:01 PM | View | Proxy | SEC | Y 2023 | ||||||
| Neumora Therapeutics, Inc. (NMRA) | 3/7/2024 4:17:04 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $496,195,000 | EPS -$3.63 | ||
| Neumora Therapeutics, Inc. (NMRA) | 3/7/2024 7:09:39 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $496,195,000 | EPS -$0.04 | Export Earnings Model | ||
| Neumora Therapeutics, Inc. (NMRA) | 11/1/2023 4:16:47 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $544,749,000 | EPS -$1.14 | ||
| Neumora Therapeutics, Inc. (NMRA) | 11/1/2023 4:03:19 PM | View | Earnings | SEC | 3Q 2023 | Assets $544,749,000 | EPS -$1.14 |